OET MRSA Texts
OET MRSA Texts
OET MRSA Texts
Text B
Guidelines: MRSA in the Workplace
• Point-of-care risk assessment
This process will determine whether you are at risk of contracting an infection and
requires you to be aware of your environment, the health status of your patient and
whether the type of task you are doing may bring you into contact with MRSA bacteria.
• Hand hygiene
Appropriate hand hygiene is the most effective way to stop the spread of MRSA. Perform
hand hygiene before and after every patient interaction and in any situation where you
may have touched contaminated surfaces or equipment.
• Personal protective equipment
Wear gloves and a gown when dealing with a patient with an MRSA infection.
• Environmental controls
Ensure that equipment and surfaces are kept clean and that bed linens and other fabrics
are regularly changed.
Text C
Deaths involving S. aureus (including MRSA)
Figure 1: Number of death certificates mentioning Staphylococcus
aureus: by methicillin resistance, England and Wales, 1993 to 2012
Note: From 2008-12, the death rate in cases related to S. aureus (including MRSA) was
higher for males than for females and increased overall with age. S. aureus deaths stood
at 1.8 per million population for men aged under 45 and 415.8 per million population for
men over 85. Among women, the rates were 1.4 per million population and 200.4 per
million population for the same age groups.
Text D
MRSA management
Due to the possibility of resistance developing rapidly, rifampicin should not
be the sole antibiotic treatment. Clindamycin or a tetracycline may be used
alone, or rifampicin and fusidic acid may be used together, for MRSA-related
infections of the skin and soft tissue. Glycopeptides such as vancomycin are
recommended if this type of infection is severe; however, if these are not
suitable, linezolid can be used, but expert advice must be sought. Linezolid is
ineffective against Gram-negative organisms and must be used with other
antibacterials for infections that also involve Gram-negative organisms.
Fusidic acid and a glycopeptide or a glycopeptide and clindamycin are
possible alternatives for skin and soft-tissue infections if a single antibacterial
has no effect.